|
PHLPP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.0293999998583E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.79870000000571E-05 |
| Normal-vs-Stage2 |
1.348480E-02 |
| Normal-vs-Stage3 |
2.97020000039616E-07 |
| Normal-vs-Stage4 |
5.83100000000059E-05 |
| Stage1-vs-Stage2 |
8.761000E-01 |
| Stage1-vs-Stage3 |
1.310040E-01 |
| Stage1-vs-Stage4 |
3.436800E-01 |
| Stage2-vs-Stage3 |
2.813800E-01 |
| Stage2-vs-Stage4 |
3.891000E-01 |
| Stage3-vs-Stage4 |
8.677600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.05650000548874E-08 |
| Normal-vs-AfricanAmerican |
6.167900E-02 |
| Normal-vs-Asian |
2.094000E-01 |
| Caucasian-vs-AfricanAmerican |
4.024000E-01 |
| Caucasian-vs-Asian |
7.044000E-02 |
| AfricanAmerican-vs-Asian |
1.395840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96879995534505E-09 |
| Normal-vs-Female |
2.498200E-02 |
| Male-vs-Female |
3.648900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.395660E-02 |
| Normal-vs-Age(41-60Yrs) |
9.98719999999453E-05 |
| Normal-vs-Age(61-80Yrs) |
1.39870000004372E-06 |
| Normal-vs-Age(81-100Yrs) |
2.442600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.523000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.260000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.113600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.362400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.172600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.268400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.338160E-01 |
| Normal-vs-Grade 2 |
7.5258000000078E-05 |
| Normal-vs-Grade 3 |
1.65668999999591E-05 |
| Normal-vs-Grade 4 |
1.4410999999992E-06 |
| Grade 1-vs-Grade 2 |
7.100800E-01 |
| Grade 1-vs-Grade 3 |
5.748200E-01 |
| Grade 1-vs-Grade 4 |
2.582600E-01 |
| Grade 2-vs-Grade 3 |
6.082000E-01 |
| Grade 2-vs-Grade 4 |
1.365410E-01 |
| Grade 3-vs-Grade 4 |
2.943400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.034320E-04 |
| Normal-vs-ccB subtype |
2.757100E-04 |
| ccA subtype-vs-ccB subtype |
8.657000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.841300E-04 |
| Normal-vs-N1 |
1.301350E-03 |
| N0-vs-N1 |
2.967400E-01 |
|
|
